SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹2,353 Cr | ₹2,110 Cr | ₹1,967 Cr | ₹1,576 Cr | ₹1,292 Cr |
What is the latest Total Liabilities ratio of SUVEN PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹2,353 Cr |
Mar2023 | ₹2,110 Cr |
Mar2022 | ₹1,967 Cr |
Mar2021 | ₹1,576 Cr |
Mar2020 | ₹1,292 Cr |
How is Total Liabilities of SUVEN PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,353 Cr | 11.52 | |
Mar2023 | ₹2,110 Cr | 7.28 | |
Mar2022 | ₹1,967 Cr | 24.78 | |
Mar2021 | ₹1,576 Cr | 21.97 | |
Mar2020 | ₹1,292 Cr | - |
Compare Total Liabilities of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹28,477.0 Cr | -1.4% | 4.1% | 74.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹436,379.0 Cr | 0.8% | 7.2% | 22.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,420.0 Cr | 0.7% | 11% | 53.3% | Stock Analytics | |
CIPLA | ₹122,010.0 Cr | -2% | 4.6% | 10.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,634.0 Cr | -1.6% | 2.8% | 24.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,788.5 Cr | -1.4% | 0.7% | -5.5% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -1.4% |
4.1% |
74.6% |
SENSEX | 0.5% |
4.2% |
8% |
You may also like the below Video Courses